GBIO Stock Summary and Trading Ideas (Generation Bio Co. | NASDAQ:GBIO)

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Generation Bio Co. trades on the NASDAQ stock market under the symbol GBIO.

As of January 30, 2026, GBIO stock price declined to $5.59 with 74,369 million shares trading.

GBIO has a beta of 1.52, meaning it tends to be more sensitive to market movements. GBIO has a correlation of 0.12 to the broad based SPY ETF.

GBIO has a market cap of $37.65 million. This is considered a Sub-Micro Cap stock.

Last quarter Generation Bio Co. reported $2 million in Revenue and -$.82 earnings per share. This beat revenue expectation by $1 million and exceeded earnings estimates by $18.45.

In the last 3 years, GBIO traded as high as $73.50 and as low as $3.00.

The top ETF exchange traded funds that GBIO belongs to (by Net Assets): VTI, VXF.

GBIO has underperformed the market in the last year with a price return of -35.0% while the SPY ETF gained +16.2%. GBIO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +0.4% and -0.9%, respectively, while the SPY returned +1.0% and 0.0%, respectively.

GBIO support price is $5.50 and resistance is $5.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GBIO shares will trade within this expected range on the day.